T. Dienemann, N. Fujii, Y. Li, S. Govani, N. Kosaraju, R.D. Bloom, H.I. Feldman, Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective study. Transpl. Int. 29, 1017–1028 (2016)
Article CAS PubMed Google Scholar
M. Hecking, M. Haidinger, D. Döller, J. Werzowa, A. Tura, J. Zhang, M.D. Säemann, Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J. Am. Soc. Nephrol. 23, 739–749 (2012)
Article CAS PubMed PubMed Central Google Scholar
D.M. Zelle, E. Corpeleijn, J. Deinum, R.P. Stolk, R.O. Gans, G. Navis, S.J. Bakker, Pancreatic β-cell dysfunction and risk of new-onset diabetes after kidney transplantation. Diabetes Care. 36, 1926–1932 (2013)
Article CAS PubMed PubMed Central Google Scholar
T. Jenssen, A. Hartmann, Post-transplant diabetes mellitus in patients with solid organ transplants. Nat. Rev. Endocrinol. 15, 172–188 (2019)
K. Tokodai, N. Amada, I. Haga, T. Takayama, A. Nakamura, The 5-time point oral glucose tolerance test as a predictor of new-onset diabetes after kidney transplantation. Diabetes Res. Clin. Pr. 103, 298–303 (2014)
S. Kesiraju, P. Paritala, U.M.R. Ch, S. Sahariah, New onset of diabetes after transplantation—an overview of epidemiology, mechanism of development and diagnosis. Transpl. Immunol. 30, 52–58 (2014)
E. Dozio, V. Corradi, M. Proglio, E. Vianello, L. Menicanti, R. Rigolini, C. Ronco, Usefulness of glycated albumin as a biomarker for glucose control and prognostic factor in chronic kidney disease patients on dialysis (CKD-G5D). Diabetes Res. Clin. Pract. 140, 9–17 (2018)
Article CAS PubMed Google Scholar
I.A. Eide, T.A.S. Halden, A. Hartmann, A. Asberg, D.O. Dahle, A.V. Reisaeter, T. Jenssen, Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria. Transpl. Int. 29, 568–578 (2016)
Article CAS PubMed Google Scholar
S. Takahashi, H. Uchino, T. Shimizu, A. Kanazawa, Y. Tamura, K. Sakai, Y. Tanaka, Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr. J. 54, 139–144 (2007)
Article CAS PubMed Google Scholar
A. Raghav, J. Ahmad, Glycated albumin in chronic kidney disease: pathophysiologic connections. Diabetes Metab. Syndr. 12, 463–468 (2018)
K. Neelofar, J. Ahmad, An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus. Glycoconj. J. 34, 575–584 (2017)
Article CAS PubMed Google Scholar
J.M. Lu, L.N. Ji, Y.F. Li, Q.M. Li, S.S. Lin, X.F. Lv, Y. Gao, Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: a multicenter, prospective study. J. Diabetes Complicat. 30, 1609–1613 (2016)
S. Bhat, M.G. Jagadeeshaprasad, V. Venkatasubramani, M.J. Kulkarni, Abundance matters: role of albumin in diabetes, a proteomics perspective. Expert Rev. Proteom. 14, 677–689 (2017)
N. Furusyo, T. Koga, M. Ai, S. Otokozawa, T. Kohzuma, H. Ikezaki, J. Hayashi, Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the kyushu and okinawa population study (KOPS). Diabetologia. 54, 3028–3036 (2011)
Article CAS PubMed Google Scholar
A. Sinangil, V. Celik, S. Barlas, Y. Koc, T. Basturk, T. Sakaci, T. Ecder, The incidence of new onset diabetes after transplantation and related factors: single center experience. Nefrologia. 37, 181–188 (2017)
J. Werzowa, G. Pacini, M. Hecking, C. Fidler, M. Haidinger, H. Brath, A. Tura, Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus. J. Diabetes Complic. 29, 1211–1216 (2015)
H.Y. Jin, K. Lee, Y.J. Kim, T.S. Park, S. Lee, S.K. Park, H.C. Yu, The degree of hyperglycemia excursion in patients of kidney transplantation (KT) or liver transplantation (LT) assessed by continuous glucose monitoring (CGM): pilot study. J. Diabetes Res. 2019, 1–10 (2019)
J. Huang, The “Chinese mode” of organ donation and transplantation. HepatoBiliary Surg. Nutr. 6, 212–214 (2017)
Article PubMed PubMed Central Google Scholar
T.S. Joseph, Wu, M. Kagoli, J.J. Kaasboll, G.A. Bjune, Integrated disease surveillance and response (IDSR) in malawi: implementation gaps and challenges for timely alert. Plos One. 13, e0200858 (2018)
A. Sharif, M. Hecking, A.P.J. De Vries, E. Porrini, M. Hornum, S. Rasoul-Rockenschaub, M.D. Säemann, Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am. J. Transpl. 14, 1992–2000 (2014)
V. Shivaswamy, B. Boerner, J. Larsen, Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr. Rev. 37, 37–61 (2016)
Article CAS PubMed Google Scholar
M. Xia, H. Yang, X. Tong, H. Xie, F. Cui, W. Shuang, Risk factors for new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis. J. Diabetes Investig. 12, 109–122 (2020)
Article PubMed PubMed Central Google Scholar
A. Sharif, S. Cohney, Post-transplantation diabetes-state of the art. Lancet Diabetes Endocrinol. 4, 337–349 (2016)
D.D. De Lucena, J.R. De Sá, J.O. Medina-Pestana, E.B. Rangel, Modifiable variables are major risk factors for posttransplant diabetes mellitus in a time-dependent manner in kidney transplant: an observational cohort study. J. Diabetes Res. 2020, 1–10 (2020)
J. Xu, L. Xu, X. Wei, X. Li, M. Cai, Incidence and risk factors of posttransplantation dia betes mellitus in living donor kidney transplantation: a single-center retrospective study in China. Transpl. Proc. 50, 3381–3385 (2018)
R. Cai, M. Wu, Y. Xing, Pretransplant metabolic syndrome and its components predict post-transplantation diabetes mellitus in Chinese patients receiving a first renal transplant. Ther. Clin. Risk Manag. 15, 497–503 (2019)
Article CAS PubMed PubMed Central Google Scholar
N.D. Bayer, P.T. Cochetti, M.S.A. Kumar, V. Teal, Y. Huan, C. Doria, S.E. Rosas, Association of metabolic syndrome with development of new-onset diabetes after transplantation. Transplantation. 90, 861–866 (2010)
Article CAS PubMed PubMed Central Google Scholar
T. Szili-Torok, W. Annema, J.L. Anderson, S.J. Bakker, U.J. Tietge, High density lipoprotein cholesterol efflux predicts incident new onset diabetes after transplantation (NODAT) in renal transplant recipients independent of high density lipoprotein cholesterol levels. Diabetes. 68, 1–32 (2019)
X. Lai, L. Zhang, J. Fang, G. Li, L. Xu, J. Ma, Z. Chen, OGTT 2-hour serum C-peptide index as a predictor of post-transplant diabetes mellitus in kidney transplant recipients. Ann. Transl. Med. 7, 538–546 (2019)
Article CAS PubMed PubMed Central Google Scholar
X. He, L. Ying, X. Ma, Y. Shen, H. Su, J. Peng, W. Jia, An additional measurement of glycated albumin can help prevent missed diagnosis of diabetes in Chinese population. Clin. Chim. Acta. 475, 188–192 (2017)
Article CAS PubMed Google Scholar
S. Sokooti, F. Klont, S.C. Tye, D. Kremer, R.M. Douwes, G. Hopfgartner, R.P.F. Dullaart, H.J.L. Heerspink, S.J.L. Bakker, Association of diuretic use with increased risk for long-term post-transplantation diabetes mellitus in kidney transplant recipients. Nephrol. Dial. Transpl. 37, 1375–1383 (2022)
J.B. Bang, C.K. Oh, Y.S. Kim, S.H. Kim, H.C. Yu, C.D. Kim, M.K. Ju, B.J. So, S.H. Lee, S.Y. Han, C.W. Jung, J.K. Kim, S.H. Lee, J.Y. Jeon, Insulin secretion and insulin resistance trajectories over 1 year after kidney transplantation: a multicenter prospective cohort study. Endocrinol. Metab. 35, 820–829 (2020)
F. Cheng, Q. Li, J.L. Wang, Z.D. Wang, F. Zeng, Y. Zhang, Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation. Saudi Pharm. J. 30, 1088–1094 (2022)
留言 (0)